ImmuCell Corporation Increase (Decrease) in Accrued Interest Receivable, Net
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Accrued Interest Receivable, Net of $230.16 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2025-08-14
- ImmuCell Corporation increase (decrease) in accrued interest receivable, net for the quarter ending 2022-03-31 was $222.38K.
- ImmuCell Corporation increase (decrease) in accrued interest receivable, net for the quarter ending 2021-12-31 was $0.00.
- ImmuCell Corporation increase (decrease) in accrued interest receivable, net for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation increase (decrease) in accrued interest receivable, net for the quarter ending 2021-06-30 was $0.00.
- ImmuCell Corporation increase (decrease) in accrued interest receivable, net for fiscal 2021 was -$495.00.
- ImmuCell Corporation increase (decrease) in accrued interest receivable, net for fiscal 2020 was -$27.26K, a 198.22% decline from fiscal 2019.
- ImmuCell Corporation increase (decrease) in accrued interest receivable, net for fiscal 2019 was $27.75K.
- ImmuCell Corporation increase (decrease) in accrued interest receivable, net for fiscal 2017 was -$24.01K, a 262.35% decline from fiscal 2016.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|---|---|
| 2023-06-30 | $230.16K 10-Q · filed 2023-08-10 | |||
| 2022-12-31 | $222.38K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | $222.38K 10-Q · filed 2025-08-14 | $222.38K derived: sum of 2 quarters · filed 2025-08-14 | $222.38K derived: sum of 3 quarters · filed 2025-08-14 | $222.38K derived: sum of 4 quarters · filed 2025-08-14 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | -$495.00 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $0.00 derived: sum of 2 quarters · filed 2022-11-21 | -$495.00 10-Q · filed 2022-11-21 | -$538.00 derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | -$495.00 10-Q/A · filed 2022-11-21 | -$538.00 derived: sum of 3 quarters · filed 2022-11-21 | -$98.00 derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | -$495.00 10-Q/A · filed 2022-11-21 | -$538.00 derived: sum of 2 quarters · filed 2022-11-21 | -$98.00 derived: sum of 3 quarters · filed 2022-11-21 | -$5.82K derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | -$43.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $397.00 derived: sum of 2 quarters · filed 2022-03-30 | -$5.33K derived: sum of 3 quarters · filed 2022-03-30 | -$27.26K 10-K · filed 2022-03-30 |
| 2020-09-30 | $440.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$5.28K derived: sum of 2 quarters · filed 2021-11-15 | -$27.21K 10-Q · filed 2021-11-15 | -$52.41K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$5.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$27.66K 10-Q · filed 2021-08-12 | -$52.85K derived: sum of 3 quarters · filed 2021-08-12 | -$38.23K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$21.93K 10-Q · filed 2021-05-13 | -$47.13K derived: sum of 2 quarters · filed 2021-05-13 | -$32.51K derived: sum of 3 quarters · filed 2021-05-13 | -$344.98K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$25.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$10.58K derived: sum of 2 quarters · filed 2021-03-30 | -$323.05K derived: sum of 3 quarters · filed 2021-03-30 | $27.75K 10-K · filed 2021-03-30 |
| 2019-09-30 | $14.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$297.85K derived: sum of 2 quarters · filed 2020-11-12 | $52.95K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$312.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $38.33K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $350.80K 10-Q · filed 2019-05-13 | |||
| 2018-03-31 | -$344.12K 10-Q · filed 2019-05-13 | -$344.12K derived: sum of 2 quarters · filed 2019-05-13 | -$346.70K derived: sum of 3 quarters · filed 2019-05-13 | -$354.48K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$2.58K derived: sum of 2 quarters · filed 2019-03-22 | -$10.36K derived: sum of 3 quarters · filed 2019-03-22 | -$24.01K 10-K · filed 2019-03-22 |
| 2017-09-30 | -$2.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$10.36K derived: sum of 2 quarters · filed 2018-11-13 | -$24.01K 10-Q · filed 2018-11-13 | -$20.07K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | -$7.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$21.43K 10-Q · filed 2018-08-13 | -$17.48K derived: sum of 3 quarters · filed 2018-08-13 | -$15.90K derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | -$13.66K 10-Q · filed 2018-05-14 | -$9.71K derived: sum of 2 quarters · filed 2018-05-14 | -$8.13K derived: sum of 3 quarters · filed 2018-05-14 | -$4.80K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $3.95K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $5.53K derived: sum of 2 quarters · filed 2018-03-29 | $8.86K derived: sum of 3 quarters · filed 2018-03-29 | $14.79K 10-K · filed 2018-03-29 |
| 2016-09-30 | $1.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $4.91K derived: sum of 2 quarters · filed 2017-11-13 | $10.84K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $3.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $9.26K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | $5.93K 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | $3.71K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |